Title of article :
Resistance to irinotecan (CPT-11) activates epidermal growth factor receptor/nuclear factor kappa B and increases cellular metastasis and autophagy in LoVo colon cancer cells
Author/Authors :
Chen، نويسنده , , Ming-Cheng and Lee، نويسنده , , Nien-Hung and Ho، نويسنده , , Tsung-Jung and Hsu، نويسنده , , Hsi-Hsien and Kuo، نويسنده , , Chia-Hua and Kuo، نويسنده , , Wei-Wen and Lin، نويسنده , , Yueh-Min and Tsai، نويسنده , , Fuu-Jen and Tsai، نويسنده , , Chang-Hai and Huang، نويسنده , , Chih-Yang، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2014
Pages :
10
From page :
51
To page :
60
Abstract :
Chemotherapy is usually applied to treat colon cancer but leads to chemoresistance, and increased metastasis and invasion. The main focus of this study is to observe effects of resistance to irinotecan (CPT-11) on metastasis, invasion and autophagy in CPT-11 resistant (CPT-11-R) LoVo colon cancer cells. CPT-11, a topoisomerase I inhibitor and a first-line chemotherapeutic drug, is used to treat colon cancer. CPT-11-R cells were constructed in a step-wise fashion with increasing CPT-11 doses. The CPT-11-R strain had a significantly lower expression of Wnt/β-catenin pathway, but induced an EGFR/IKKα/β/NF-κB pathway with elevated cell cycle, metastasis and basal autophagy.
Keywords :
metastasis , Autophagy , CPT-11 , Chemoresistance , NF-?B
Journal title :
Cancer Letters
Serial Year :
2014
Journal title :
Cancer Letters
Record number :
1824666
Link To Document :
بازگشت